Researchers from The University of Texas MD Anderson Cancer Center (TX, USA) have discovered new details of how the enzyme, acetyl-CoA synthetase 2 (ACSS2), supports brain tumor growth in a nutrient-starved environment. The results from this study, recently published in Molecular Cell, may provide a new target for future cancer therapies.
Restricted Content / Members Only
You cannot view this content because It is available to members only. Please Login or Register to view this area.